Caroline Gaudy-Marqueste

3PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMedicinal and biomolecular chemistry not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 14, 2026
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.

|Feb 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre study.

Vasiliki Nikolaou, Ander Mayor, Vincent Sibaud

|Nov 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma.

Nausicaa Malissen, Nicolas Macagno, Samuel Granjeaud

Pageof 1

Frequent Collaborators

2 joint publications

Nicolas Macagno

2 joint publications

Robert Ballotti

1 joint publications

Nausicaa Malissen

1 joint publications

Samuel Granjeaud